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Introduction
The term neural tube defect (NTD) describes any
malformation of the embryonic brain and/or spinal cord,
including spina bifida, anencephaly and encephalocoele.
NTDs are among the most common birth defects,
contributing to miscarriage, infant mortality, severe
congenital abnormalities and serious disability.1
Several studies have shown that periconceptional
use of folic acid has an effective role in the prevention of
NTDs.2-5 Czeizel et al in a cohort-controlled trial in
Hungary reported that periconceptional multivitamin
supplementation causes a reduction in certain congenital
abnormalities, including NTDs.2 Wilson et al showed the
efficacy of supplementary folic acid in the prevention of
NTDs.3 Bower et al showed that periconceptional folic acid
supplementation in Western Australia since 1996 had
reduced anencephaly (32%), spina bifida (23%), and
encephalocoele (34%).4 Berry et al reported that
periconceptional folic acid supplementation reduced the
rate of NTDs in China.5
Studies have also shown that 50-80% of NTDs can
be prevented if a woman consumes sufficient amount of
folic acid daily before conception, and throughout the first
trimester of her pregnancy.3,6 Over the last 2 decades, in
several countries, national public health authorities have
recommended the consumption of folic acid (at least 400
microgram) as supplementation from 1 month before
pregnancy until the 12th week of pregnancy.5,7
Folic acid is the fully oxidised monoglutamyl form
of the water-soluble vitamin commercially used in
supplements. In metabolism process, folic acid is converted
into co-enzyme forms required in numerous one-carbon
transfer reactions involved in the synthesis, inter-conversion
and modification of nucleotides, amino acids and other
essential structural and regulatory compounds. Folic acid
deficiencies can interfere with DNA synthesis, reduced cell
growth and the destruction of cell division.8
Despite folic acid recommendations and national
campaigns, in many countries periconceptional intake of
additional folic acid remains inadequate.9-12
Abdulrazzaq et al9 in the UAE, and Sayers et al10 in
Ireland reported that actual periconceptional use of folic
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Abstract
Objective: To assess the knowledge and practice of urban Iranian pregnant women regarding periconceptional
folic acid intake for neural tube defect (NTD) prevention.
Methods: The population-based study was done on 676 primiparous women in an urban area in Golestan province
in northern Iran from June to November, 2008. A questionnaire was completed by the subjects regarding their
knowledge of folic acid. Questionnaires were administered to women who were seeking routine antenatal care at
health centres, private gynaecological clinic and the Dezyani Gynaecologic and Obstetric Hospital. Questions
covered knowledge and use of folic acid supplements and demographic and socioeconomic characteristics. 
Results: Out of the 676 women surveyed, 96.2% reported that they heard of folate. Of these, only 27.6% knew
that folate was something important in the prevention of neural tube defects. Overall, 20.12% of the total women
took folic acid during periconceptional period. The most common information sources on folate were healthcare
service (54.5%). Besides, 37.6% of the subjects who heard about folate were aware that green leafy vegetables
were fortified with folic acid. In univariate analysis, knowledge and intake of folic acid was not associated with
education and the age of women.
Conclusion: A healthcare plan for intervention to increase the knowledge and intake of folic acid by pregnant
women during the protective period is required.
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acid in women was 8.3% and 4.5% respectively. Also,
Braekke and Staff in Oslo have shown that only 17% of all
women had started taking folic acid supplementation
preconceptionally.11 Colls et al in a Mediterranean area
reported that only 6.9% did so during the effective period
from 4 weeks before conception to 4 weeks after
conception.12
Furthermore, NTDs account for 21.7% of all notified
congenital birth defects in northern Iran, with an incidence
of 28 per 10,000 livebirths during the period 1998-2005.1 To
our knowledge, no study has been conducted on the
awareness and intake of additional folic acid among women
of child-bearing age in the Golestan province of northern
Iran. Thus, this questionnaire-based study was done to
assess the knowledge and practice of urban pregnant
women regarding periconceptional folic acid intake for
NTD prevention.
Subjects and Methods
This cross-sectional population-based study was
done involving primiparous women in the urban area of
Golestan province in north of Iran from June to November,
2008. Ethical approval for the study was obtained from the
Ethics Committee of the Golestan University of Medical
Sciences. 
The Golestan province, located in northern Iran, has
a population of about 1.8 million and covers an area of
about 20,460 square kilometers with an annual rate of more
than 31000 deliveries. In estimating the true prevalence of
folic acid awareness in the general female population, it was
assumed that this would be approximately similar to the
numbers previously reported.13
Sample size for 5% of awareness about folic acid
and zinc from a study with certitude 0.015 and type 1 error
(0.05) was estimated. The 676 subjects were selected by
convenient purposive sampling from among women who
were registered with Primary Healthcare Centers (PHCs),
private gynaecology clinic and the Dezyani Gynaecology
and Obstetric Hospital. After all the subjects aged 18-45
years agreed to participate in the study, qualified nurses and
health educators were instructed to structurally interview
them and complete a questionnaire.
The questionnaire covered the knowledge and use
of folic acid supplements, source of knowledge, intake of
dietary and folic acid supplement, and the potential benefit
of taking folic acid supplements. The questionnaire was
anonymous and competed on a voluntary basis. It consisted
of two different groups of questions: the first part
comprised of variables of socio-demographic status
(maternal age, level of education, family income) and
pregnancy planning (yes/no) for current and previous
pregnancies. The term 'pregnancy planning' referred to a
decision by the women to stop using contraception in order
to achieve pregnancy, and the consideration about changing
the dietary habits prior to conception.
The second part included questions about the
awareness and knowledge of FA's role, supplementation and
fortification, the sources of information (the media, their
doctor or a friend); timing of the information (before
conception; before the last menstrual period; during or after
pregnancy), the practice of FA intake in current pregnancies.
The Statistical Package for Social Sciences (SPSS)
version 11.5 was used for statistical analysis. To examine
the association of awareness about and intake of folic acid
supplement with selected socio-demographic profile of
women, univariate logistic regression analyses were done.
The results of these analyses were expressed as odds ratios
(OR) and their 95% confidence intervals (95% CI). An OR
was considered significant if its 95% CI excluded 1.00. The
level p < 0.05 was considered to be the cut-off value for
significance.
Results
The mean age of the women included in the study
was 23.4 ± 4.1 years. The mean age of gestational stage at
which women were interviewed was 24 weeks. In terms of
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Table-1: Knowledge and intake of folic acid among Iranian women.
Characteristics Frequency Ever heard of folic Intake of folic acid
Age groups(years) n (%) Acid n (%) Periconceptional n (%) First Trim n (%) Any Time After First time n (%)
<20 255(35.4) 247(35.2) 103(34.4) 103(36.2) 32(35.9)
20-25 331(45.9) 319(45.6) 141(47.2) 131(46.1) 37(41.6)
25-30 105(14.6) 104(14.9) 44(14.7) 37(13) 16(18)
>30 30(4.1) 30(4.3) 11(3.7) 13(4.6) 4(4.5)
Level of education 
Illiterate 15(2.1) 13(1.85) 7(2.3) 2(0.7) 3(3.4)
Primary 271(37.48) 261(37.2) 91(30.4) 109(38.2) 43(48.3)
Secondary 137(18.94) 135(19.2) 59(19.7) 57(20) 16(18)
High School 272(37.6) 265(37.7) 134(44.6) 104(36.5) 24(27)
University 28(3.9) 28(4) 9(3) 13(4.6) 3(3.3)
age 23.5% women were under 20, and 5.3% over 30 years
old. Pregnancies were planned in 91.3% of the cases. The
association of knowledge and intake of supplementary folic
acid with age and education of the women was calculated
(Table-1). As high as 96.2% of the women reported that they
had heard about folic acid. Despite these results, few
women (27.6%) understood that the use of folic acid
supplement during periconceptional period could help
prevent NTDs. When asked how they had been made aware
of the benefits of taking folic acid, the most commonly cited
sources of information were the healthcare service (54.5%),
radio and TV (17.8%) and midwifery (11.2%).
Most of the women (92.3%) reported that they had
taken folic acid at some period, but 20.1% subjects
consumed folic acid during the periconceptional period of
pregnancy. Univariate analysis showed that the awareness
about folic acid was not associated with the level of
education and age of the women (Table-2). Also, univariate
of selected socio-demographic characteristics of the studied
women and intake of folic acid before pregnancy showed
that there was no significant association between the intake
of folic acid and education or age of the women (Table-3). 
Knowledge about types of natural foods rich in folic
acid was also assessed. Surprisingly, only 37.6% of the
women could identify any. Ninety-nine percent of the
women had positive attitude about using folic acid for the
prevention of NTDs in their next pregnancy. 
Discussion
The awareness of folic acid in primiparous women in
northern Iran was found to be 27.6%. This rate is much
lower than in the other middle eastern countries,9,14 but
higher than those among Thai and Japanese women.15,16
Abdulrazzaq et al9 in the UAE and Bener et al14 in
Qatar showed that the awareness of folic acid in women was
46.6% and 54%, respectively.
Also, Kondo et al15 reported that less than 15% of
Japanese women were aware of a link between folic acid and
NTDs. Furthermore, Nawapun and Phupong16 showed that
the awareness of folic acid was 24.4% among Thai women. 
In our study, although 96.2% of women had heard
of folic acid, only 20.1% of the women took folic acid
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Table-2: Univariate analysis of the association of socio-demographic
characteristics of women and the awareness about folic acid.
Characteristics OR (%) 95%CI P-value
Age groups(years)
<20 0.881 0.394-1.97 0.758
20-24 0.77 0.347-1.70 0.52
25-30 0.8 0.335-1.908 0.615
>30 1 - -
Level of education
Illiterate 0.485 0.124-1.903 0.299
Primary 0.387 0.174-0.863 0.06
Secondary 0.631 0.275-1.447 0.277
High School 0.659 0.299-1.453 0.301
University 1 - -
Table-3: Univeriate analysis of the association of age and level of
education of women and the intake of folic acid.
Characteristics OR (%) 95%CI P-value
Age groups(years)
<20 1.33 0.37-4.801 0.660
20-24 0.721 0. 21-2.47 0.604
25-30 0.690 0.185-2.584 0.582
>30 1 - -
Level of education
Illiterate 1 0.082-12.163 1
Primary 0.675 0.152-3.006 0.606
Secondary 0.702 0.150-3.294 0.654
High School 0.571 0.129-2.526 0.460
University 1 - -
Table-4: Folate awareness rate and actual periconceptional use among women in different studies.
Study Author Year Sample Folate Actual
Size (n) awareness (%) periconceptional use (%)
UK Wild et al.21 1996 300 41 NA
Ireland Sayers et al.10 1997 335 63.6 2.7
USA Kloeblen17 1999 251 57 45
Spain Coll et al.12 2000 1,000 50.6 6.9
Canada Morin et al.18 2002 1,240 70 25
USA van den Berg et al.23 2002 16,555 50 40
China Ren et al.24 2004 693 30 15
U A Emirates Abdulrazzaq et al.9 2003 336 46.6 8.3
Honduras Ying Wu et al.25 2007 636 45 25
Crovatia Gjergja et al.13 2003 569 71.7 14.4
Qatar Bener et al.14 2004 1,480 54 20.3
Thailand Nawapun & Phupong.16 2005 401 24.4 9.7
Iran Present study. 2008 676 27.6 20.1
during the periconceptional period. Folic acid intake rate
is similar to a study in Qatar (20.3%),14 but our rate is
lower than the rate from other reports related to the USA
(45%)17 and Canada(25%).18 Also, our folic acid taken
rate is higher than the studies from Spain (6.9%),12
Thailand (9.7%),16 Ireland (2.7%)10 and the United Arab
Emirates (8.3%)9 (Table-4). The folic acid taken rate in
our study indicates an urgent need of a systematic plan for
improvement in the use of periconceptional folic acid
supplement.
In this study, 37.6% subjects identified natural foods
rich in folic acid. This rate is almost similar to other
studies.16,17 Nawapun and Phupong among Thai women
reported that 32.4% women could identify types of natural
foods rich in folic acid.16 Also, Kloeblen study among 251
low-income, predominantly minority, pregnant women in
Atlanta, USA, determined that only 30% of the women
could list any food sources of folate.17
This may suggest that folic acid intake through diet
in the population could be due to the impact of healthcare
recommendations. Despite the existence of scientific
evidence on the effectiveness of folic acid supplementation
in the prevention of NTDs, and its recommendation by
healthcare authorities, only 20.2% women in our setting
took this vitamin properly. This finding is similar to other
reports from developed and developing countries where
20.3-70% of women take folic acid during the
periconceptional period.14,18,19
The poor intake of folic acid in our region may be
due to certain reasons. First, the awareness of the population
about the need to take folic acid is low (27.6%). This is
considerably lower than the report from The Netherlands
with 74%.20 Also a reason may be that folic acid is not
prescribed in time. A late medical appointment is an
important factor in this regard. The other reason may be
disorders in the absorption of folic acid, because
gastrointestinal disorders and h.pylori infections are high in
the region.21,22
Another reason may be the misperception that folic
acid consumption increases gastrointestinal disorders.
According to Univarinte analysis, we found no
relation between educational level, age of mothers, and the
awareness about folic acid. Also, educational level and age
of mothers did not relate to the correct intake of folic acid,
but in other studies these relations have been reported.14,16
Bener et al’s study14 showed that awareness of
folic acid among Qatari women was significantly
associated with education of the mother. Also, women
with higher education (from high school to university
level) knew more about folic acid, and used it more often
in the periconceptional and first trimester period.14 A
study among Thai women also showed that the
educational level was related to the intake of folic acid
during the correct period.16
The sources of information reported by the subjects
were not similar to those reported in previous
studies.12,14,16,23,24 In our study, a majority of women
recalled hearing about folate from the healthcare service,
but in some studies, a majority of women recalled hearing
about folate from their doctors.14,24
Bener et al reported that the most common sources
of information about folate were the physicians (63.4%)
and newspaper/magazine/books (21.7%).14 French et al
also reported that a majority of women recalled hearing
about folate from their doctors.24 Furthermore, in several
studies the majority of women recalled hearing about
folate from the media.13,16,23 Gjergja et al reported that
among Croatian pregnant women, the media (TV, radio,
newspapers, internet, etc.) was the most frequent source
of information about folic acid (40.68%). The physician
was the second source of information (30.82%).13
Nawapun and Phupong also reported that the media was
the most frequent source of information (48.6%) for Thai
women. The other sources of information were
doctors/healthcare personnel (20.8%) and
friends/relatives (6.7%).16
In our study, however, 96.2% of the women had at
least heard about folic acid. Only 27.6% of them knew
about its role against NTDs. Also, only 20.1% of the
women took folic acid during the periconceptional period.
Our findings indicated low awareness and knowledge
about folic acid among Iranian women in urban area in
northern Iran. Further efforts are needed to inform the
population and promote optimal use of folic acid
supplements at the correct time and in enough dosage.
Promoting knowledge about the importance of folic acid
intake via healthcare personnel and media should
contribute to the efforts.
Conclusion
There is a strong need for immediate public health
education initiative. Information to specifically inform
women about the need to take folic acid for the prevention
of NTDs by all tiers of healthcare system and media, can
improve the intake of folic acid during the protective period.
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